Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neuronetics Inc STIM

Healthcare Medical Devices
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength... see more

Recent & Breaking News (NDAQ:STIM)

The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen

Benzinga.com  January 16, 2019

Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue

GlobeNewswire January 7, 2019

Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 15, 2018

NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment

PR Newswire November 13, 2018

Neuronetics Reports Third Quarter 2018 Financial and Operating Results

GlobeNewswire November 6, 2018

Neuronetics to Report Third Quarter 2018 Financial Results and Host Conference Call

GlobeNewswire October 23, 2018

Neuronetics to be Added to the Russell 2000®, 3000® and Microcap® Indexes

GlobeNewswire October 1, 2018

Neuronetics Reports Second Quarter 2018 Financial and Operating Results

GlobeNewswire August 14, 2018

Neuronetics, Inc. to Report Second Quarter 2018 Financial Results and Host Conference Call

GlobeNewswire July 31, 2018

Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Closing of Initial Public Offering and the Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire July 2, 2018

Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering

GlobeNewswire June 28, 2018